These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 15625928)

  • 21. Mother and daughter carrying the same KCNJ11 mutation but with a different response to switching from insulin to sulfonylurea.
    Russo C; Salina A; Aloi C; Iafusco D; Lorini R; d'Annunzio G
    Diabetes Res Clin Pract; 2011 Nov; 94(2):e50-2. PubMed ID: 21871684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influencing factors of glycaemic control in patients attending different types of urban health care settings in Malaysia.
    Ahmad B; Khalid BA; Zaini A; Hussain NA; Quek KF
    Diabetes Res Clin Pract; 2011 Jul; 93(1):e12-4. PubMed ID: 21397969
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of continuous subcutaneous insulin infusion (CSII) in patients with classical contraindications to its use.
    Berkeley J; Lunt H; Frampton C
    Diabet Med; 2007 Dec; 24(12):1496-7. PubMed ID: 17976206
    [No Abstract]   [Full Text] [Related]  

  • 24. [Plaster, tablet or inhalation? New dosage forms for insulin].
    von Susanne Heinzl B
    Med Monatsschr Pharm; 2006 Mar; 29(3):90-2. PubMed ID: 16550881
    [No Abstract]   [Full Text] [Related]  

  • 25. The egg or the chicken? Further data on whether good compliance to multi-injection insulin therapy should be a criterion for insulin pump therapy, or does insulin pump therapy improve compliance?
    Lombardo F; Iafusco D; Salzano G; Piscopo A; Saitta G; Pisani F; De Luca F; Prisco F
    J Pediatr; 2007 Dec; 151(6):e23-4. PubMed ID: 18035124
    [No Abstract]   [Full Text] [Related]  

  • 26. Efficacy of Dongsulin (rDNA human insulin) in a normal clinical practice setting.
    Ahmedani MY; Fawwad A; Basit A; Nawaz A
    Pak J Biol Sci; 2008 Oct; 11(19):2356-9. PubMed ID: 19137871
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 5(th) Annual Symposium on Self-Monitoring of Blood Glucose (SMBG) applications and beyond, May 3-5, 2012, Dublin, Ireland.
    Hoey H; Mlinac A; Tran CT; Schlaeger C
    Diabetes Technol Ther; 2012 Dec; 14(12):1155-73. PubMed ID: 23216339
    [No Abstract]   [Full Text] [Related]  

  • 28. Metformin as an adjunctive therapy for NIDDM.
    Waterman PE
    Nurse Pract; 1996 Apr; 21(4):150-2. PubMed ID: 8801483
    [No Abstract]   [Full Text] [Related]  

  • 29. Relationship of baseline HbA1c and HbA1c reduction following insulin therapy in Type 2 diabetes.
    Giugliano D; Esposito K
    Diabet Med; 2011 Feb; 28(2):247. PubMed ID: 21219438
    [No Abstract]   [Full Text] [Related]  

  • 30. Case Study: using a continuous glucose monitoring system in a patient with diabetes and beta-thalassemia hemoglobinopathy.
    Al-Futaisi A; Wali Y; El-Beshlawi I; Al-Riyami S; Almahrezi A
    Pediatr Hematol Oncol; 2009; 26(7):515-9. PubMed ID: 19863207
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Guidelines for glycemic control.
    Clement S
    Clin Cornerstone; 2004; 6(2):31-9. PubMed ID: 15628691
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bolus calculator settings in well-controlled type 1 diabetes patients (glycated hemoglobin < 7%) treated with insulin pumps.
    Matejko B; Grzanka M; Kieć-Wilk B; Małecki MT; Klupa T
    J Diabetes Sci Technol; 2013 May; 7(3):800-1. PubMed ID: 23759415
    [No Abstract]   [Full Text] [Related]  

  • 33. Hemoglobin A1c values and CGM.
    Blevins T
    Diabetes Technol Ther; 2012 Oct; 14(10):971; author reply 972. PubMed ID: 23013204
    [No Abstract]   [Full Text] [Related]  

  • 34. [Self monitoring of blood glucose: tool for successful diabetes therapy].
    Hummel M
    MMW Fortschr Med; 2012 Nov; 154(20):65-8. PubMed ID: 23234124
    [No Abstract]   [Full Text] [Related]  

  • 35. [Critical questions on diabetes therapy and their sequelae. HbA1c: may it be more than 7 after all?].
    Aumiller J
    MMW Fortschr Med; 2009 Oct; 151(42):14-6. PubMed ID: 19938773
    [No Abstract]   [Full Text] [Related]  

  • 36. SARS-CoV-2 infection-related diabetes mellitus.
    Beliard K; Wilkes M; Yau M; Aluf A; Rapaport R
    J Diabetes; 2021 Jun; 13(6):523-524. PubMed ID: 33660918
    [No Abstract]   [Full Text] [Related]  

  • 37. Insulin pens.
    Gebel E
    Diabetes Forecast; 2011 Jan; 64(1):54-5. PubMed ID: 21337831
    [No Abstract]   [Full Text] [Related]  

  • 38. Should A1C targets be individualized for all people with diabetes? Arguments for and against.
    Teoh H; Home P; Leiter LA
    Diabetes Care; 2011 May; 34 Suppl 2(Suppl 2):S191-6. PubMed ID: 21525454
    [No Abstract]   [Full Text] [Related]  

  • 39. Should the target A1C level be less than 7 percent? No: The case for modest glycemic control in patients with type 2 diabetes.
    Barry HC
    Am Fam Physician; 2012 Dec; 86(12):1-2. PubMed ID: 23316991
    [No Abstract]   [Full Text] [Related]  

  • 40. Inhaled insulin helps type 2 diabetics.
    Health News; 2004 Jan; 10(1):15. PubMed ID: 15002388
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.